全文获取类型
收费全文 | 31718篇 |
免费 | 2497篇 |
国内免费 | 922篇 |
专业分类
耳鼻咽喉 | 610篇 |
儿科学 | 1039篇 |
妇产科学 | 535篇 |
基础医学 | 4462篇 |
口腔科学 | 833篇 |
临床医学 | 2440篇 |
内科学 | 5191篇 |
皮肤病学 | 1116篇 |
神经病学 | 2720篇 |
特种医学 | 1429篇 |
外国民族医学 | 2篇 |
外科学 | 4195篇 |
综合类 | 3038篇 |
现状与发展 | 2篇 |
预防医学 | 1729篇 |
眼科学 | 967篇 |
药学 | 2363篇 |
1篇 | |
中国医学 | 475篇 |
肿瘤学 | 1990篇 |
出版年
2024年 | 38篇 |
2023年 | 248篇 |
2022年 | 557篇 |
2021年 | 971篇 |
2020年 | 588篇 |
2019年 | 850篇 |
2018年 | 1040篇 |
2017年 | 995篇 |
2016年 | 922篇 |
2015年 | 927篇 |
2014年 | 1348篇 |
2013年 | 1682篇 |
2012年 | 1282篇 |
2011年 | 1419篇 |
2010年 | 1189篇 |
2009年 | 1261篇 |
2008年 | 1365篇 |
2007年 | 1305篇 |
2006年 | 1111篇 |
2005年 | 996篇 |
2004年 | 915篇 |
2003年 | 1011篇 |
2002年 | 1710篇 |
2001年 | 1986篇 |
2000年 | 2121篇 |
1999年 | 1417篇 |
1998年 | 1341篇 |
1997年 | 1203篇 |
1996年 | 719篇 |
1995年 | 405篇 |
1994年 | 261篇 |
1993年 | 176篇 |
1992年 | 190篇 |
1991年 | 179篇 |
1990年 | 162篇 |
1989年 | 144篇 |
1988年 | 102篇 |
1987年 | 81篇 |
1986年 | 64篇 |
1985年 | 131篇 |
1984年 | 130篇 |
1983年 | 111篇 |
1982年 | 83篇 |
1981年 | 91篇 |
1980年 | 72篇 |
1979年 | 68篇 |
1978年 | 43篇 |
1977年 | 52篇 |
1976年 | 25篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
11.
12.
13.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
14.
15.
16.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
17.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(5):803-811
ObjectivesTo review the evidence pertaining to the association between cow’s milk protein allergy and recurrent acute otitis media and otitis media with effusion.MethodsThe CENTRAL, Web of Science, EMBASE, MEDLINE, LILACS databases, and gray literature were searched.ResultsFour studies were included, identifying the prevalence rates: 0.2% of delayed speech due to chronic otitis media with effusion in 382 children with cow’s milk protein allergy, 10.7% of cow’s milk protein allergy in 242 children who underwent ENT procedures, 40% of cow’s milk protein allergy in 25 children with recurrent otitis media with effusion and higher tendency to otitis media in children with cow’s milk protein allergy of 186 children (1.5 + 0.6 vs. 0.4 + 0.1; p < 0.1).ConclusionConsidering the characteristics and methodological variations of the identified studies, it is not possible to state that there is reliable evidence of an association between cow’s milk protein allergy and otitis media. 相似文献
18.
O. Morris M. Fairclough J. Grigg C. Prenant A. McMahon 《Journal of labelled compounds & radiopharmaceuticals》2019,62(1):4-23
Affinity peptide and protein‐ (APP) based radiotracers are an increasingly popular class of radiotracer in positron emission tomography (PET), which was once dominated by the use of small molecule radiotracers. Radiolabelled monoclonal antibodies (mAbs) are important examples of APPs, yet a preference for smaller APPs, which exhibit fast pharmacokinetics and permit rapid PET aided diagnosis, has become apparent. 18F exhibits favourable physical characteristics for APP radiolabelling and has been described as an ideal PET radionuclide. Notwithstanding, 18F radiolabelling of APP is challenging, and this is echoed in the literature where a number of diverse approaches have been adopted. This review seeks to assess and compare the approaches taken to 18F APP radiolabelling with the intention of highlighting trends within this expanding field. Generic themes have emerged in the literature, namely the use of mild radiolabelling conditions, a preference of site‐specific methodologies with an impetus for short, automated procedures which produce high‐yielding [18F]APPs. 相似文献
19.
20.
Shafqat R. Chaudhry Ilana S. Lendvai Sajjad Muhammad Philipp Westhofen Johannes Kruppenbacher Lukas Scheef Henning Boecker Dirk Scheele Rene Hurlemann Thomas M. Kinfe 《Brain stimulation》2019,12(3):643-651